Quarterly Activities/Appendix 4C Cash Flow Report
Filed with ASX ·
6ix is reading this filing.
Earlier from Bubs Australia
- Bubs Secures Permanent US FDA Approval for Infant Formula
- FY26 Results Presentation
- FY26 Appendix 4E and Preliminary Annual Report
- FY26 Results
- FY26 Trading Update
Follow Bubs Australia into a list and get an email when it puts out news.
Follow Bubs Australia